Class I phosphoinositide 3-kinases (PI3Ks) control cellular growth, but are also essential in insulin signaling and glucose homeostasis. Pan-PI3K inhibitors thus generate substantial adverse effects, a reality that has plagued drug development against this target class. We present here evidence that a high affinity binding module with the capacity to target all class I PI3K isoforms can facilitate selective degradation of the most frequently mutated class I isoform, PI3K alpha, when incorporated into a cereblon-targeted (CRBN) degrader. A systematic proteomics study guided the fine tuning of molecular features to optimize degrader selectivity and potency. Our work resulted in the creation of WJ112-14, a PI3K alpha-specific nanomolar degrader that should serve as an important research tool for studying PI3K biology. Given the toxicities observed in the clinic with unselective PI3K alpha inhibitors, the results here offer a new approach toward selectively targeting this frequently mutated oncogenic driver.Bifunctional degraders built from unselective inhibitors of the phosphoinositide 3-kinase (PI3K) family can support selective degradation of specific isoforms, such as the frequently mutated oncoprotein PI3K alpha.

A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3Kα / W.T. Jauslin, M. Schild, T. Schaefer, C. Borsari, C. Orbegozo, L. Bissegger, S. Zhanybekova, D. Ritz, A. Schmidt, M. Wymann, D. Gillingham. - In: CHEMICAL SCIENCE. - ISSN 2041-6520. - 15:2(2024 Jan 03), pp. 683-691. [10.1039/d3sc04629j]

A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3Kα

C. Borsari;
2024

Abstract

Class I phosphoinositide 3-kinases (PI3Ks) control cellular growth, but are also essential in insulin signaling and glucose homeostasis. Pan-PI3K inhibitors thus generate substantial adverse effects, a reality that has plagued drug development against this target class. We present here evidence that a high affinity binding module with the capacity to target all class I PI3K isoforms can facilitate selective degradation of the most frequently mutated class I isoform, PI3K alpha, when incorporated into a cereblon-targeted (CRBN) degrader. A systematic proteomics study guided the fine tuning of molecular features to optimize degrader selectivity and potency. Our work resulted in the creation of WJ112-14, a PI3K alpha-specific nanomolar degrader that should serve as an important research tool for studying PI3K biology. Given the toxicities observed in the clinic with unselective PI3K alpha inhibitors, the results here offer a new approach toward selectively targeting this frequently mutated oncogenic driver.Bifunctional degraders built from unselective inhibitors of the phosphoinositide 3-kinase (PI3K) family can support selective degradation of specific isoforms, such as the frequently mutated oncoprotein PI3K alpha.
Settore CHIM/08 - Chimica Farmaceutica
   Exploiting the DNA damage response to induce degradation of proteins
   ExploDProteins
   European Commission
   Horizon 2020 Framework Programme
   866345
3-gen-2024
Article (author)
File in questo prodotto:
File Dimensione Formato  
42_2024_Chemical Science_PROTACs.pdf

accesso aperto

Descrizione: Article
Tipologia: Publisher's version/PDF
Dimensione 1.6 MB
Formato Adobe PDF
1.6 MB Adobe PDF Visualizza/Apri
d4sc90011a.pdf

accesso aperto

Descrizione: Correction
Tipologia: Publisher's version/PDF
Dimensione 128.07 kB
Formato Adobe PDF
128.07 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1035128
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact